livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.
makro-albumon 2 mg por szuszpenziós injekcióhoz
medi-radiopharma kft. - seroalbuminum humanum macroaggregatum -
forlax 4 g por oldathoz
ipsen pharma - makrogol -
olopeg koncentrátum belsőleges oldathoz
mip pharma gmbh - makrogol; citromsav, vízmentes; nátrium-klorid; kálium-klorid; nátrium-citrát, -
forlax 10 g por belsőleges oldathoz
ipsen consumer healthcare - makrogol - other gynecologicals
makro-albumon por injekció készítésére
medi-radiopharma kft. - seroalbuminum humanum macroaggregatum -
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - daganatellenes szerek - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
bezalip 400 mg retard filmtabletta
actavis group ptc ehf. - bezafibrate -
omeprazole-astrazeneca 10 mg kapszula
astrazeneca kft. - omeprazol -
omeprazole-astrazeneca 20 mg kapszula
astrazeneca kft. - omeprazol -